Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Defang Li

Showing results (161-170 of 165) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 165 results.
Nature Communications|March 28, 2026
Retraction Note: A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancerFangfei Li, Jun Lu, Jin Liu, et al.
Biomaterials|March 31, 2015
A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of microRNAs in osteoclastsJin Liu, Lei Dang, Defang Li, et al.
Nature Medicine|February 10, 2015
Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategyChao Liang, Baosheng Guo, Heng Wu, et al.
Nature Communications|March 8, 2016
Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formationDefang Li, Jin Liu, Baosheng Guo, et al.
Nature Communications|June 19, 2025
Author Correction: Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formationDefang Li, Jin Liu, Baosheng Guo, et al.
Pageof 17

Showing results (161-170 of 165) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 165 results.
Nature Communications|March 28, 2026
Retraction Note: A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancerFangfei Li, Jun Lu, Jin Liu, et al.
Biomaterials|March 31, 2015
A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of microRNAs in osteoclastsJin Liu, Lei Dang, Defang Li, et al.
Nature Medicine|February 10, 2015
Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategyChao Liang, Baosheng Guo, Heng Wu, et al.
Nature Communications|March 8, 2016
Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formationDefang Li, Jin Liu, Baosheng Guo, et al.
Nature Communications|June 19, 2025
Author Correction: Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formationDefang Li, Jin Liu, Baosheng Guo, et al.
Pageof 17